2006
DOI: 10.1016/j.diabres.2005.09.016
|View full text |Cite
|
Sign up to set email alerts
|

Enhancement of serum lipoprotein lipase mass levels by intensive insulin therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2006
2006
2019
2019

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…However, this may overestimate lipolysis, since VLDL hydrolysis will contribute to glycerol Ra. Although this will be a small percentage of total glycerol Ra in the fasting state, during an hyperinsulinaemic clamp this contribution may increase, since insulin increases lipoprotein lipase mass and activity [35,36]. Measurement of NEFA Ra using an isotope of one of the more abundant circulating fatty acids such as palmitic acid or oleic acid has also been used as a measure of whole-body lipolysis, although this may lead to an underestimation of lipolysis due to intracellular recycling of fatty acids into triacylglycerol.…”
Section: Discussionmentioning
confidence: 99%
“…However, this may overestimate lipolysis, since VLDL hydrolysis will contribute to glycerol Ra. Although this will be a small percentage of total glycerol Ra in the fasting state, during an hyperinsulinaemic clamp this contribution may increase, since insulin increases lipoprotein lipase mass and activity [35,36]. Measurement of NEFA Ra using an isotope of one of the more abundant circulating fatty acids such as palmitic acid or oleic acid has also been used as a measure of whole-body lipolysis, although this may lead to an underestimation of lipolysis due to intracellular recycling of fatty acids into triacylglycerol.…”
Section: Discussionmentioning
confidence: 99%
“…In early clinical studies, LPL levels were analyzed using postheparin plasma (Sexena U et al, 1989;Peterson et al,1990). However, a sensitive immunoassay using a specific monoclonal antibody against LPL has demonstrated the presence of LPL mass in preheparin serum (Kobayashi J et al, 1993;Tornvall P et al, 1995).Preheparin LPL massis low in type 2 diabetes patients and is increased by insulin therapy (Miyashita Y et al, 2002).Preheparin LPL mass is considered to reflectinsulin action in the whole body (Miyashita Y et al, 2006).These reports indicate that preheparin LPL mass is a good marker for evaluating insulin action. In this study, although the change inpreheparin LPL mass was not significantly different between two groups, mean preheparin LPL mass increased in degludec group but decreased in glargine group.…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, non‐HDL cholesterol has been shown to have a strong predictive power for future cardiovascular disease even from childhood . Intensified insulin treatment is known to enhance the action of lipoprotein lipase, leading to increased HDL cholesterol levels in people with Type 1 diabetes . Furthermore, low HDL cholesterol levels do not seem to persist through adulthood .…”
Section: Introductionmentioning
confidence: 99%